# FDA Inspection 1259069 - Degowin  Blood Center - December 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/degowin-blood-center/ee709d85-1b0d-4aac-ac4e-af6fea20d325
Source feed: FDA_Inspections

> FDA Inspection 1259069 for Degowin  Blood Center on December 12, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1259069
- Company Name: Degowin  Blood Center
- Inspection Date: 2024-12-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1259069 - 2024-12-12](https://www.keypedia.com/records/fda_inspections/degowin-blood-center/3480d88c-a658-4071-95ca-3eb99fd05291)
- [FDA Inspection 1094007 - 2019-06-06](https://www.keypedia.com/records/fda_inspections/degowin-blood-center/efee9fad-df28-4842-bee1-afe67b915ccd)
- [FDA Inspection 1001567 - 2017-02-15](https://www.keypedia.com/records/fda_inspections/degowin-blood-center/76919f7f-6fe6-4068-aa68-ad97de1ea151)
- [FDA Inspection 915232 - 2015-02-13](https://www.keypedia.com/records/fda_inspections/degowin-blood-center/7ccceee8-1331-42aa-b46c-560d53e5989f)
- [FDA Inspection 805206 - 2012-10-24](https://www.keypedia.com/records/fda_inspections/degowin-blood-center/1acdc010-c60c-4356-862d-468614546190)

Company: https://www.keypedia.com/companies/degowin-blood-center/507368cf-70db-4e35-9d2b-fefd35a9c2aa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d